Enterprise leaders say recipe for AI agents is matching them to existing processes — not the other way around

Eamily Evans
By Eamily Evans
Block Chain

Share This Post



Global enterprises Block and GlaxoSmithKline (GSK) are exploring AI agent proof of concepts in financial services and drug discovery. Read More



Source link

spot_img

Related Posts

AI Is a Godsend for Criminals Forging Fake Art

Illustration by Tag Hartman-Simkins / Futurism. Source: Willem...

How Much Water Does the A.I. Industry Use?

new video loaded: How Much Water Does the...

QNAP TurboStation TS-264-8G review: A powerful NAS with upgrade potential

At a glanceExpert's Rating Pros High transfer speed Compact design Many upgrade...

Google's year in review: 8 areas with research breakthroughs in 2025

This year saw new AI models, transformative products...

Google’s and OpenAI’s Chatbots Can Strip Women in Photos Down to Bikinis

Some users of popular chatbots are generating bikini...

Gene therapy for Huntington’s disease showed great promise in 2025

spot_img
Previous article
Anthropic Settles High-Profile AI Copyright Lawsuit Brought by Book Authors
Next article
Anthropic launches Claude for Chrome in limited beta, but prompt injection attacks remain a major concern

© AmericanJuggalo.com | All Rights Reserved.